Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) Could ureteral wall thickness have an impact on the operative and post-operative...
Journal Information
Vol. 43. Issue 9.
Pages 474-479 (November 2019)
Share
Share
Download PDF
More article options
Visits
4
Vol. 43. Issue 9.
Pages 474-479 (November 2019)
Original article
Could ureteral wall thickness have an impact on the operative and post-operative parameters in ureteroscopic management of proximal ureteral stones?
¿Podría el espesor de la pared ureteral afectar a los parámetros intra y postoperatorios de la ureteroscopia para el tratamiento de piedras ureterales proximales?
Visits
4
K. Saricaa, B. Eryildirimb,
Corresponding author
bilaleryildirim@yahoo.com

Corresponding author.
, H. Akderec, E. Camurb, K. Sabuncub, O. Elibold
a Kafkas University, Medical School, Department of Urology, Kars, Turkey
b Dr. Lutfi Kirdar Kartal Training and Research Hospital, Department of Urology, Istanbul, Turkey
c Trakya University, Medical School, Department of Urology, Edirne, Turkey
d Dr. Lutfi Kirdar Kartal Training and Research Hospital, Department of Radiology, Istanbul, Turkey
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (3)
Table 1. Evaluation of patient and stone characteristics in both groups.
Table 2. Evaluation of the outcomes of the procedures in terms of success rates as well as early post-operative follow-up data.
Table 3. Correlation of UWT with other parameters.
Show moreShow less
Abstract
Aim

To evaluate the possible impact of stone impaction in terms of ureteral wall thickness (UWT) on the success and procedure related parameters of ureteroscopic management in proximal ureteral calculi.

Patients and methods

82 patients with proximal ureteric stones were included and were divided into two subgroups where UWT was >5 mm in 38 cases; and <5 mm in 44 cases. Stone size, degree of hydronehrosis, diameter of proximal ureteral lumen, UWT and patient's demographics were evaluated. Semi-rigid ureteroscopy with Ho-YAG laser was performed and the possible impact of UWT as an objective parameter for stone impaction on the success rates and procedure related parameters was evaluated.

Results

Mean patient age and stone size values were 47.55 ± 1.78 years and 8.17 ± 0.29 mm respectively. Regarding the impact of UWT value at the stone site for the parameters mentioned above stone free rates particularly at 1-week after the procedure was higher in group 2 and the rate of residual fragments as well as the need for double J stent placement was higher in group 1. Additionally, mean duration of the procedures was significantly longer in Group 1 during which pathologic alterations were significantly higher in ureteral wall at stone site were observed in these cases (p:0.0243).

Conclusions

UWT may be used to predict the success of ureteroscopic management and other procedure related parameters for proximal ureteral stones in an effective manner. With this approach a more rational operative plan with higher success rates, limited complications and auxiliary procedures could be made.

Keywords:
Ureteral wall thickness
Ureteral calculi
Ureteroscopic management
Resumen
Objetivo

Evaluar la relación del espesor de la pared ureteral (EPU) con el éxito y parámetros relacionados con la ureteroscopia para el tratamiento de cálculos ureterales proximales.

Pacientes y métodos

se incluyeron 82 pacientes con cálculos ureterales proximales y se dividieron en dos subgrupos de acuerdo con el grosor de la pared ureteral: un grupo con 38 pacientes, EPU > 5 mm; y el segundo con 44, EPU < 5 mm. Se evaluaron los siguientes parámetros: tamaño de la piedra, grado de hidronefrosis, diámetro de la luz ureteral proximal, el EPU y los datos demográficos de los pacientes. Se realizó ureteroscopia semirrígida con láser Ho-YAG y se evaluó el posible impacto del EPU sobre las tasas de éxito y los parámetros relacionados con el procedimiento.

Resultados

La media de edad de los pacientes y el tamaño de los cálculos fue 47.55 ± 1.78 años y 8.17 ± 0.29 mm respectivamente. Con respecto al impacto del valor de EPU sobre los parámetros mencionados anteriormente, la tasa libre de cálculos una semana después del procedimiento fue mayor en el grupo 2 y la tasa de fragmentos residuales, así como la necesidad de colocación de catéter doble J, fueron mas altas en el grupo 1. Adicionalmente, la duración media del procedimiento fue significativamente más larga en el Grupo 1, y se observaron alteraciones patológicas en la pared ureteral significativamente mayores en estos casos (p: 0.0243).

Conclusiones

el EPU es un factor útil al predecir el éxito del tratamiento ureteroscópico y otros parámetros relacionados con el procedimiento para los cálculos ureterales proximales. Con este enfoque, se podría realizar un plan operativo más adecuado, con mayores tasas de éxito, menos complicaciones y procedimientos adicionales.

Palabras clave:
Espesor de la pared ureteral
Cálculos ureterales
Manejo ureteroscópico

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos